Skip to Content

Pacific Biosciences of California Inc PACB

Morningstar Rating
$1.73 +0.07 (3.92%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PACB is trading at a 259% premium.
Price
$1.67
Fair Value
$8.79
Uncertainty
Extreme
1-Star Price
$2.19
5-Star Price
$1.45
Economic Moat
Brm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PACB is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.66
Day Range
$1.671.78
52-Week Range
$1.1613.70
Bid/Ask
$1.72 / $1.73
Market Cap
$471.18 Mil
Volume/Avg
5.2 Mil / 10.1 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.16
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
796

Comparables

Valuation

Metric
PACB
TWST
BNGO
Price/Earnings (Normalized)
Price/Book Value
0.705.600.41
Price/Sales
2.1611.150.63
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
PACB
TWST
BNGO
Quick Ratio
8.124.881.04
Current Ratio
9.285.511.46
Interest Coverage
−20.82−103,596.50−43.61
Quick Ratio
PACB
TWST
BNGO

Profitability

Metric
PACB
TWST
BNGO
Return on Assets (Normalized)
−15.31%−18.39%−59.94%
Return on Equity (Normalized)
−40.23%−22.73%−90.03%
Return on Invested Capital (Normalized)
−16.22%−21.58%−74.32%
Return on Assets
PACB
TWST
BNGO
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
YcvnwxlkjChwbky$177.5 Bil
Stryker Corp
SYK
RtpnczvyqqYcpd$129.9 Bil
Boston Scientific Corp
BSX
FdgknjbzYgtml$114.0 Bil
Medtronic PLC
MDT
VjyjvmqtKlltqcw$101.9 Bil
Edwards Lifesciences Corp
EW
XdqtflmhbDmzqtlq$52.1 Bil
DexCom Inc
DXCM
DcyxfwwvhLsqm$44.2 Bil
Koninklijke Philips NV ADR
PHG
CtbhmcqcpSmzfss$24.3 Bil
Zimmer Biomet Holdings Inc
ZBH
NbvjqhfdsMfnl$22.7 Bil
Steris PLC
STE
ScrmjtshVwdtrh$22.2 Bil
Align Technology Inc
ALGN
HtnpxdhyDvplrl$18.9 Bil

Sponsor Center